Skip to content

Radiomics of Contrast-enhanced ultrasound with Artifificial Intelligence for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma

Radiomics of Contrast-enhanced ultrasound with Artifificial Intelligence for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034578
Enrollment
Unknown
Registered
2020-07-10
Start date
2020-07-01
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

Gold Standard:Pathologic diagnosis
Index test:The&#32
Artificial&#32
Intelligent&#32
model&#32
of&#32
MVI&#32
based&#32
on&#32

Sponsors

Sun Yat-Sen University Cancer Center (SYSUCC)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Confirmed or suspected hepatocellular carcinoma by CT/MR, undergoing surgical resection in SYSUCC after CEUS. (2) No arterial embolization or ablation therapy was accepted. (3) Hepatocellular carcinoma nodules are less than 9cm and within 6cm of the depth of ultrasonic probe. (4) Can understand and be willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) No lesions are found in ultrasound examination. (2) Poor lesion display during CEUS examination due to operator's manipulation or patient's respiratory problems. (3) Postoperative pathology do not evaluate microvascular invasion. (4) Surgical pathology confirmed pathological findings other than hepatocellular carcinoma.

Design outcomes

Primary

MeasureTime frame
Microvascular invasion;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactZhou Jianhua

Sun Yat-Sen University Cancer Center (SYSUCC)

zhoujh@sysucc.org.cn+86 13711757623

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026